MedicinMan | Dr. Surinder Kumar
Dr. Surinder Kumar
Thursday, April 30, 2026
24.1
C
Bengaluru
Hot topics
The Pill is Now a Commodity – Can ‘Beyond the Pill’ Models Work in India?
The pill is now a commodity that many of these companies provide at heavy discounts, making money off everything ‘beyond the pill’. Investors are betting heavily on the potential of technological innovation to transform the way healthcare is delivered.
The Economic Times reported that in 2021, India recorded investments of $77 billion across 1,266 deals including 164 large deals worth $58 billion. While the money reduced in 2022, the reason wasn’t a lack of faith in this business model.
Meanwhile, the pharmaceuticals industry that is most affected by this quiet but rapid change, is grappling with its entrenched culture. Its current business is so profitable that everything else pales in comparison.
‘Build, measure, learn, build again’ – a mantra of the health tech industry is alien to pharma that doesn’t learn, build or measure after launching a product.
Pharma also thinks of its customers as doctors alone and does precious little to connect with patients, or caregivers. People who are not sick do not feature on their radar at all. These are cultural values that keep pharma focused on the pill and discourage thinking beyond it.
A social media poll conducted by MedicinMan showed almost predictable responses. 100+ respondents who work in the pharma industry in India were quite clearly divided. 48% of them wanted to know what beyond the pill actually meant, while 23% wanted to know how to execute it.
The rest felt that the ultra-competitive environment in the Indian generics market required very high share-of-voice tactics (19%), or that their customers demanded product information (9%).
Has Indian Pharma Seen The Longevity Tsunami Coming?
Why India Must Urgently Reinvent Healthcare for a 100-Year...
PM-JAY – Low Hanging Fruit for Healthcare Fraud?
PM-JAY is already attracting systematic fraud and abuse, and...
Dr. Tarun Gupta Tribute Issue
Editor's Note - This issue of MedicinMan is dedicated to the memory of Dr. Tarun Gupta, TG as he was fondly called. Executive Editor, Salil Kallianpur, dear friend Subrato Banerjee and long-time MedicinMan patron Vivek Hattangadi, pen their tributes to TG.
Does Public-Private Partnership Benefit The Public?
Does This Public-Private Partnership Benefit The Public?” (Tuesday, July...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Hot topics
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
The Strait of Hormuz—Why Geopolitics Is Now Core to India’s Healthcare Strategy
"Those who cannot remember the past are condemned to...
PM-JAY – Low Hanging Fruit for Healthcare Fraud?
PM-JAY is already attracting systematic fraud and abuse, and...
Are Managers Really Necessary?
In the organisational context, LEADERSHIP appears more glamorous than...
Patient Centered Pharma – Pipe Dream or Possible?
To me, patient centricity is as fascinating a concept as it is contradictory. It is fascinating because it puts power into the hands of the patient. And it is contradictory because pharma does not like giving away power over its messages or processes. Pharma has traditionally never enjoyed interaction and has depended on ‘pushing’ messages across rather than having ‘conversations’. It probably also explains why we make do with medical reps who are not the sharpest knives in the drawer and scarcely invest in sharpening them.
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Will the GLP Battle Now Shift from Injectable to Oral?
In India’s million-strong retail pharmacy universe, oral weight-loss pills...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Subhendu K Datta has taken on a new role as Senior Vice President (Sales & Marketing) – India & Nepal SBU Head at Micro...
In his new position, he will lead teams across...
Why Private Equity is the New Kingmaker in Pharma & MedTech
The PE Playbook: Why Private Equity is the New...
Tez Health and the New Race to Bring Healthcare Home
Tez Health and the New Race to Bring Healthcare...
Is Pharma M&A Slowing Down Amidst Geopolitical Friction?
The pharmaceutical industry stands at a critical juncture in...
Newsletter
Get important news delivered directly to your inbox and stay connected!